BiotechTube
Home/Alterity Therapeutics/David Stamler, M.D.
DS

David Stamler, M.D.

Chief Executive Officer

Alterity Therapeutics

Therapeutic Areas

Neurodegenerative DiseasesParkinson's DiseaseMultiple System AtrophySynucleinopathies

Alterity Therapeutics Pipeline

DrugIndicationPhase
ATH434Multiple System Atrophy (MSA)Phase 2
Discovery MPACsNeurodegenerative Diseases (e.g., Tauopathies)Discovery

Leadership Team at Alterity Therapeutics

GK
Geoffrey Kempler
Non-Executive Chairman
AM
Andrew M. Saik
Chief Financial Officer & Company Secretary
DD
Dr. David F. Tang
Chief Operating Officer
DR
Dr. Rebecca L. Wood-Horrill
Vice President, Clinical Development
DS
Dr. Steven Gourlay
Chief Medical Officer
View full Alterity Therapeutics profile